Cookie Settings
We use cookies to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement and Cookie Statement.
PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. |
Stimulated sample |
Unseparated fraction | After separation |
CD137 MicroBead Kit, humanFigure 1PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. | CD137 MicroBead Kit, humanFigure 1PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. |
Unstimulated control |
Unseparated fraction | After separation |
CD137 MicroBead Kit, humanFigure 1PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. | CD137 MicroBead Kit, humanFigure 1PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. |
PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. |
Stimulated sample |
Unseparated fraction | After separation |
CD137 MicroBead Kit, humanFigure 1PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. | CD137 MicroBead Kit, humanFigure 1PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. |
Unstimulated control |
Unseparated fraction | After separation |
CD137 MicroBead Kit, humanFigure 1PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. | CD137 MicroBead Kit, humanFigure 1PBMCs of a CMV + donor were stimulated overnight with PepTivator™ CMV pp65 or left untreated. The responding CD137 + T cells were separated using the CD137 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Cells were additionally stained with CD8-FITC. |
Seems like you are coming from USA!
Do you want to visit our website in your country?
Copyright © 2022 Miltenyi Biotec and/or its affiliates. All rights reserved.